CU23750B7 - Compuestos de motilida - Google Patents

Compuestos de motilida

Info

Publication number
CU23750B7
CU23750B7 CU20070261A CU20070261A CU23750B7 CU 23750 B7 CU23750 B7 CU 23750B7 CU 20070261 A CU20070261 A CU 20070261A CU 20070261 A CU20070261 A CU 20070261A CU 23750 B7 CU23750 B7 CU 23750B7
Authority
CU
Cuba
Prior art keywords
compounds
group
motilida
formula
substituents
Prior art date
Application number
CU20070261A
Other languages
English (en)
Other versions
CU20070261A7 (es
Inventor
Mark A Burlingame
Yandong Li
Hao Zheng
Yue Chen
Hong Fu
Simon James Shaw
Yong Li
David C Myles
Christopher Carreras
Yaoquan Lyu
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CU20070261A7 publication Critical patent/CU20070261A7/es
Publication of CU23750B7 publication Critical patent/CU23750B7/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

Compuestos que tienen una estructura de acuerdo con la fórmula (I), para ser empleados en el tratamiento de enfermedades que involucran una disminución de la motilidad gástrica. ESPACIO PARA LA FÓRMULA (I) en la que (A) Ra es (i) OR1; O(CH2)mC(=CO)R2; (iii) OC(=O)R4; (iv) OS(O2)N(R3R3A); (v) O(CH2)nNHR5; (vi) N(H)S(O2)R6; (vii) OCH2CH2OCH2CH2C(=O)R2; (viii) OCH2CH2OCH2CH2NHR5; (B) RB se selecciona del grupo constituido por alquilo C2-C4, alquelino C3-C4, o alquinilo C3-C4, restos cicloalifaticos de 3 o 4 miembros y heterocicloalifaticos de 3 o 4 miembros, estando sustituidos opcionalmente cada miembro del grupo con uno o mas sustituyentes seleccionados del grupo por OH, CH y halogeno; (C) Rc es H u OH; (D) Rd es H o Me; (E) Re es H u OH; y (F) Rf es H o Me; en los que R1 y R6 son sustituyentes.
CU20070261A 2005-05-24 2007-11-23 Compuestos de motilida CU23750B7 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68461205P 2005-05-24 2005-05-24
US71540605P 2005-09-08 2005-09-08
US74889805P 2005-12-08 2005-12-08
US11/416,519 US7582611B2 (en) 2005-05-24 2006-05-02 Motilide compounds

Publications (2)

Publication Number Publication Date
CU20070261A7 CU20070261A7 (es) 2009-07-16
CU23750B7 true CU23750B7 (es) 2012-01-31

Family

ID=37452327

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20070261A CU23750B7 (es) 2005-05-24 2007-11-23 Compuestos de motilida

Country Status (19)

Country Link
US (1) US7582611B2 (es)
EP (1) EP1888082B1 (es)
JP (1) JP4197359B2 (es)
KR (1) KR100956465B1 (es)
AP (1) AP2337A (es)
AU (1) AU2006249555B2 (es)
BR (1) BRPI0611374A2 (es)
CA (1) CA2609494C (es)
CU (1) CU23750B7 (es)
EA (1) EA014711B1 (es)
ES (1) ES2392860T3 (es)
GE (1) GEP20094854B (es)
IL (1) IL186752A (es)
MA (1) MA29485B1 (es)
MX (1) MX2007014255A (es)
NO (1) NO20076464L (es)
NZ (1) NZ562891A (es)
TN (1) TNSN07436A1 (es)
WO (1) WO2006127252A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009518396A (ja) * 2005-12-08 2009-05-07 ファイザー・インク エリスロマイシン化合物の３’−ジメチルアミノ基を脱メチルする方法
EP2431380A3 (en) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
KR101575703B1 (ko) 2009-02-27 2015-12-10 라퀄리아 파마 인코포레이티드 모틸린 수용체에 대해 작용제 활성을 가진 옥시인돌 유도체
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983103A (en) * 1973-01-19 1976-09-28 Pliva Pharmaceutical And Chemical Works N-(Benzenesulfonyl)-erythromycylamine derivatives
YU35369B (en) 1973-01-19 1980-12-31 Pliva Zagreb Process for preparing n-(benzenesulfonyl)-erythromycilamine derivatives
US3855200A (en) * 1973-04-23 1974-12-17 Polska Akademia Nauk Instytut Process for preparing 8-hydroxyerthromycin a and intermediates therefor
YU35363B (en) 1974-01-14 1980-12-31 Pliva Zagreb Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
IT1196041B (it) * 1984-03-08 1988-11-10 Pierrel Spa Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
JPS60218321A (ja) 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
DK0579770T3 (da) * 1991-04-09 1996-11-04 Abbott Lab Makrocycliske lactamprokinetika
US5523418A (en) * 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DK0623021T3 (da) * 1992-01-21 1999-02-08 Abbott Lab 4"-deoxyerythromycinderivater
US5470961A (en) * 1992-03-19 1995-11-28 Takeda Chemical Ind., Ltd. 14 and/or 15-hydroxy 6,9 hemiacetal erythromycin derivatives
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
JP2000509712A (ja) 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
ES2244001T3 (es) * 1996-07-05 2005-12-01 Biotica Technology Limited Eritromicinas y procedimiento para su preparacion.
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
US5922849A (en) * 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
AU9646098A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6084079A (en) * 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
WO2001060833A2 (en) * 2000-02-18 2001-08-23 Kosan Biosciences, Inc. Motilide compounds
CN100358912C (zh) * 2000-09-01 2008-01-02 中外制药株式会社 红霉素衍生物的制备方法
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
JP2002241391A (ja) 2001-02-15 2002-08-28 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
EP1365726A2 (en) * 2001-02-15 2003-12-03 Kosan Biosciences, Inc. Method for evaluating therapeutic efficacy
SI1532131T1 (sl) * 2002-08-29 2009-04-30 Pfizer Motilidne spojine
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US20060075011A1 (en) * 2004-09-23 2006-04-06 Fujitsu Limited System and method for optimizing polynomial expressions in a processing environment
TW200633714A (en) 2004-12-28 2006-10-01 Chugai Pharmaceutical Co Ltd Drugs for the treatment and/or prophylaxis of gastroparesis symptom

Also Published As

Publication number Publication date
TNSN07436A1 (fr) 2009-03-17
IL186752A (en) 2011-10-31
JP2008542268A (ja) 2008-11-27
BRPI0611374A2 (pt) 2010-08-31
MX2007014255A (es) 2008-01-22
CA2609494C (en) 2010-12-21
KR20080013922A (ko) 2008-02-13
AP2007004220A0 (en) 2007-10-31
GEP20094854B (en) 2009-12-10
EA014711B1 (ru) 2011-02-28
IL186752A0 (en) 2008-02-09
NZ562891A (en) 2011-01-28
HK1117739A1 (en) 2009-01-23
CA2609494A1 (en) 2006-11-30
AU2006249555A8 (en) 2006-11-30
AP2337A (en) 2011-12-14
EP1888082B1 (en) 2012-09-12
US7582611B2 (en) 2009-09-01
EP1888082A4 (en) 2008-12-17
NO20076464L (no) 2008-02-22
WO2006127252A1 (en) 2006-11-30
US20060270616A1 (en) 2006-11-30
CU20070261A7 (es) 2009-07-16
EP1888082A1 (en) 2008-02-20
AU2006249555A1 (en) 2006-11-30
MA29485B1 (fr) 2008-05-02
JP4197359B2 (ja) 2008-12-17
AU2006249555B2 (en) 2009-07-16
KR100956465B1 (ko) 2010-05-07
ES2392860T3 (es) 2012-12-14
EA200702290A1 (ru) 2008-04-28

Similar Documents

Publication Publication Date Title
CU23750B7 (es) Compuestos de motilida
CY1123801T1 (el) Παραγωγα αρωματικου σουλφοναμιδιου
CL2019003636A1 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson.
CO2020002961A2 (es) Activadores de piruvato quinasas para usar en el tratamiento de trastornos en la sangre
PE20190509A1 (es) 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas
UY36371A (es) Compuestos de indolcarboxamida inhibidores de quinasas tipo btk y tipo tec
MX391850B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
PE20191474A1 (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cancer
MX394462B (es) ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS.
CR8472A (es) Indoles,1h- indazoles,1,2- benzisoxazoles y 1,2 benzisotiazoles,y preparacion y usos de los mismos
UY29177A1 (es) Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
MX2021006804A (es) Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
PE20181345A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cancer
ECSP066951A (es) Indazoles, benzotiazoles, benzoisotiazoles, benzisoxazoles, y preparación y usos de estos
MX2017014375A (es) Moduladores del ccr2.
EP4628094A3 (en) BAFF-R ANTIBODIES AND THEIR USES
DOP2006000219A (es) Indoles de acilo, composiciones que contienen dichos compuestos y procedimientos de uso
MX2017010062A (es) [9,10-dimetoxi-3-(2-metilpropil)-1h,2h,3h,4h,6h,7h,11bh-pirido-[2 ,1-a]isoquinolin-2-il]metanol y compuestos, composiciones y metodos relacionados con los mismos.
CL2009000447A1 (es) Compuestos derivados de (1h-pirrolo{2,3-b}piridin-5-il)-sulfonamido-benzamida sustituida; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento del cancer, a travez de la inhibicion de raf.
CO2021006482A2 (es) Ureas cíclicas
AR104174A1 (es) Oxadiazoles sustituidos con deuterio
AR111233A1 (es) Inhibidores de tyk2, usos y métodos para la producción de los mismos
ECSP034810A (es) Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6
TN2017000158A1 (en) Carbazole derivatives
CY1119371T1 (el) Υποκατεστημενες ενωσεις καρβοξαμιδιων τετραϋδροκαρβαζολης και καρβαζολης χρησιμες ως αναστολεις κινασων

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)